http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017188288-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
filingDate | 2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a5ee3715eb6b576c23b8d39ca154883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f10089cf3d900d789dd929fbccb4deb1 |
publicationDate | 2017-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2017188288-A1 |
titleOfInvention | 5-substituted azabenzimidazole derivative having ampk activation action |
abstract | Provided is a compound useful as an AMPK activator. A compound represented by formula (I) or a pharmaceutically acceptable salt thereof. [In formula (I): L represents -NR1-, =N-, -O-, -S-, -SO2-, -CR2R3- or =CR2-; the broken line represents the presence or absence of a bond; X represents -CR4R5- or -O-; Y represents optionally substituted heteroaryl or optionally substituted heterocyclyl; Z represents =CR6- or =N-; R1 represents hydrogen, halogen, hydroxy, cyano, nitro, carboxy, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, etc.; R2 and R3 independently represent hydrogen, halogen, hydroxy, cyano, nitro, carboxy, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, etc.; R4 and R5 independently represent hydrogen, halogen, hydroxy, cyano, nitro, carboxy, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, etc.; R6 represents hydrogen, halogen, hydroxy, cyano, nitro, carboxy, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, etc.; R7, R8 and R9 independently represent hydrogen, halogen, hydroxy, cyano, nitro, carboxy, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, etc.; R10 and R11 independently represent hydrogen, halogen, hydroxy, cyano, nitro, carboxy, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, etc.; and R12 represents hydrogen or optionally substituted alkyl.] |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11407768-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10478425-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10406140-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11279702-B2 |
priorityDate | 2016-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 725.